Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology
最後，食品由以色列創新管理局（IIA）和廚房中心資助，並將獲得使用Evogene人工智能技術的許可
REHOVOT, Israel, April 2, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and development utilizing cutting edge computational biology technologies, across multiple market segments and The Kitchen FoodTech Hub (TKH), the foodtech incubator and investment arm of Israeli food giant Strauss Group, have jointly announced the establishment of Finally Foods Ltd.
以色列雷霍沃特，2024 年 4 月 2 日 /PRNewswire/ — Evogene Ltd。(Nasdaq: EVGN)（TASE: EVGN）是一家領先的計算生物學公司，旨在利用尖端的計算生物學技術，在多個細分市場徹底改變基於生命科學的產品發現和開發，以及 廚房食品科技中心 (TKH)以色列食品巨頭施特勞斯集團旗下的食品科技孵化器和投資部門共同宣佈成立 終於食品有限公司。
'Finally Foods' is an AI-driven company specializing in molecular farming for the food sector, committed to providing sustainable alternative sources to animal-based proteins. The company's mission is to modify plants as "bioreactors" to produce these proteins efficiently and environmentally responsibly. Leveraging Evogene's GeneRator AI technology, the company aims for short R&D cycles and rapid time-to-market.
'Finally Foods'是一家人工智能驅動的公司，專門從事食品行業的分子農業，致力於爲動物性蛋白質提供可持續的替代來源。該公司的使命是將植物改造爲 “生物反應器”，以高效、環保的方式生產這些蛋白質。利用 Evogene 的 生成器人工智能 技術，該公司的目標是縮短研發週期和縮短上市時間。
According to average market reports, the global alternative proteins market was valued at around USD 17.6 billion in 2022, with an anticipated average CAGR of 12%, expected to reach USD 55 billion by 2032[1]. 'Finally Foods' is poised to capture a share in this growing sector, leveraging the revolutionary potential of molecular farming – an efficient and environmentally friendly method for producing valuable proteins.
根據平均市場報告，2022年全球替代蛋白市場的價值約爲176億美元，預計平均複合年增長率爲12％，預計到2032年將達到550億美元[1]。利用分子農業的革命性潛力，“Finally Foods” 有望在這個不斷增長的領域佔據一席之地，分子農業是一種生產有價值蛋白質的高效、環保的方法。
'Finally Foods' has secured pre-seed funding from TKH and the Israeli Innovation Authority (IIA). Evogene holds approximately 40% stake in the company, with the remaining ownership divided among TKH and the founding team – CEO Dafna Gabbay, a seasoned entrepreneur, and CTO Dr. Basia J. Vinocur, an expert in agricultural biotechnology.
“Finally Foods” 已獲得TKH和以色列創新管理局（IIA）的種子前資金。Evogene持有該公司約40％的股份，其餘所有權分配給TKH和創始團隊——首席執行官達夫娜·加貝，一位經驗豐富的企業家，以及首席技術官巴西亞·維諾庫爾博士，農業生物技術專家。
Ofer Haviv, President & CEO of Evogene, expressed his enthusiasm for this new venture, stating, "We are thrilled to embark on this new segment, marking a milestone for Evogene as we continue to drive innovation and growth in the Life Science industry. By harnessing the power of our GeneRator AI tech-engine, molecular farming has the potential to revolutionize the food industry and promote healthier diets worldwide."
Evogene總裁兼首席執行官奧弗·哈維夫， 表達了他對這家新合資企業的熱情，他說：“我們很高興能進入這個新領域，這標誌着Evogene在我們繼續推動生命科學行業創新和增長的過程中具有里程碑意義。通過利用我們的力量 生成器人工智能 作爲科技引擎，分子農業有可能徹底改變食品行業，並在全球範圍內促進更健康的飲食。”
"'Finally Foods' is one of the rare cases where we see an extremely strong founding team, in Dafna and Basia, coupled with a proven technology platform based on the leading AI engine of Evogene" said Amir Zaidman, Chief Business Officer of The Kitchen Hub. "Establishing the company under the framework of The Kitchen and investing the pre-seed round was an easy decision in this case."
他說：“'Finally Foods'是我們在Dafna和Basia看到一支非常強大的創始團隊，再加上基於Evogene領先人工智能引擎的成熟技術平台的罕見案例之一。” 阿米爾·扎伊德曼，廚房中心首席商務官。“在這種情況下，在The Kitchen的框架下建立公司並投資種子輪融資是一個簡單的決定。”
Dafna Gabbay, Co-Founder & CEO of Finally Foods, expressed her confidence, stating, "I believe that with Evogene's cutting edge technology, TKH's leading position in the FoodTech industry and with Dr. Vinocur's vast experience – 'Finally Foods' has full potential to emerge as a promising company in the alternative proteins sector. Molecular farming represents a catalyst towards global food security and a more sustainable future, and I am proud to lead 'Finally Foods' to take an important part towards supporting this crucial vision for the world."
Finally Foods聯合創始人兼首席執行官達夫娜·加貝， 表達了她的信心，她說：“我相信，憑藉Evogene的尖端技術、TKH在食品科技行業的領先地位以及Vinocur博士的豐富經驗，'Finally Foods'完全有可能成爲替代蛋白領域一家有前途的公司。分子農業是全球糧食安全和更可持續未來的催化劑，我很自豪能夠帶領'Finally Foods'在支持這一世界重要願景方面發揮重要作用。”
About Evogene:
關於 Evogene：
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene Ltd.（納斯達克股票代碼：EVGN，TASE：EVGN）是一家利用大數據和人工智能的計算生物學公司，旨在通過利用尖端技術來提高成功概率，同時減少開發時間和成本，從而徹底改變基於生命科學的產品的開發。
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene 建立了三種獨特的技術引擎- 微升壓 AI， ChemPass AI 和 生成器人工智能。每個技術引擎都專注於發現和開發基於以下核心成分之一的產品：微生物（MicroBoost）、小分子（ChemPass AI）和遺傳元素（生成器人工智能)。
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its five subsidiaries including:
Evogene利用其技術引擎通過戰略合作伙伴關係和合作開發產品，其五家子公司包括：
1. Biomica Ltd. () developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
1。 Biomica 有限公司 () 開發和推進基於微生物組的新型療法，以治療人類疾病 微增強人工智能;
2. Lavie Bio Ltd. () - developing and commercially advancing, microbiome based ag-biologicals powered by MicroBoost AI;
2。 Lavie Bio 有限公司 ()-開發和商業推進基於微生物組的農業生物製劑，由 微增強人工智能;
3. AgPlenus Ltd. () -developing next generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
3。 agPlenus 有限公司 ()-開發下一代農業化學品，以實現有效和可持續的作物保護 ChemPass AI;
4. Canonic Ltd. () – developing medical cannabis products based on decoding plant genetics for optimized therapeutic effect powered by GeneRator AI; and
4。 Canonic 有限公司 () — 基於解碼植物遺傳學開發醫用大麻產品，以優化治療效果 生成器人工智能； 和
5. Casterra Ag Ltd. ()– developing and marketing superior castor seed varieties producing high yield and high-grade oil content, on an industrial scale for the biofuel and other industries powered by GeneRator AI.
5。 Casterra Ag 有限公司 () — 以工業規模爲生物燃料和其他由以下驅動的行業開發和銷售產量高、含油量高的優質蓖麻種子品種 生成器人工智能。
For more information, please visit: .
想要查詢更多的信息, 請訪問:.
About The Kitchen Hub:
關於《廚房中心》：
Founded in 2015 by the Strauss-Group as a part of the Israeli Innovation Authority incubators' program, The Kitchen is a seed investor and a FoodTech focused incubator.
The Kitchen由施特勞斯集團於2015年創立，是以色列創新局孵化器計劃的一部分，是一家種子投資者，也是一家專注於食品科技的孵化器。
The Kitchen addresses global food challenges by harnessing Israel's renowned innovation ecosystem. We strive to make the world's food chain more productive, affordable, sustainable and healthy by investing in and nurturing cutting-edge technology startups.
The Kitchen通過利用以色列著名的創新生態系統來應對全球食品挑戰。我們通過投資和培育尖端科技初創企業，努力提高世界食物鏈的生產力、負擔得起、可持續和健康。
Some examples of our areas of interest are: improved agricultural processes, supply chain technologies, efficient food processing, sensors for food safety and quality, prolonged shelf life and reduction of food spoilage, smart packaging, ingredients and products with new health benefits, improved nutritional profiles, reduction of environmental footprint and more.
我們感興趣的領域的一些例子包括：改進農業流程、供應鏈技術、高效的食品加工、食品安全和質量傳感器、延長保質期和減少食品變質、智能包裝、具有新健康益處的配料和產品、改善的營養狀況、減少環境足跡等。
In addition to a capital investment, the incubator provides the portfolio companies with benefits such as: close mentorship from the incubator's team; access to expertise and know-how from within the Strauss-Group and its partners; connections with global F&B companies and access to international investors.
除資本投資外，孵化器還爲投資組合公司提供諸多好處，例如：孵化器團隊的密切指導；獲得施特勞斯集團及其合作伙伴內部的專業知識和專有技術；與全球餐飲公司的聯繫以及接觸國際投資者的渠道。
Our vision is: Better Industry; Better Food; Better World
我們的願景是：更好的工業；更好的食物；更美好的世界
We believe that technological innovation can overcome the challenges of the food industry and are teaming up with the best FoodTech entrepreneurs to turn our vision into a reality.
我們相信技術創新可以克服食品行業的挑戰，並且正在與最好的食品科技企業家合作，將我們的願景變爲現實。
More on
更多內容
About Finally Foods Ltd:
關於《最後的食物》 有限公司:
Finally Foods Ltd. is a new AI-driven company specializing in molecular farming for the food sector. It was co-founded by Dafna Gabbay, CEO, a seasoned entrepreneur, and Dr. Basia J. Vinocur, CTO an expert in agricultural biotechnology. The company was formed in collaboration with Evogene Ltd., a leading computational biology company and The Kitchen FoodTech Hub (TKH), the FoodTech incubator and the investment arm of the Strauss Group. Finally Foods produces animal-based proteins by modifying plants to serve as "bioreactors", leveraging Evogene's AI technology. Its first target protein is Casein.
Finally Foods Ltd. 是一家由人工智能驅動的新公司，專門從事食品行業的分子農業。它由首席執行官、經驗豐富的企業家達夫娜·加貝和農業生物技術專家巴西亞·維諾庫爾博士共同創立。該公司由領先的計算生物學公司Evogene Ltd. 以及廚房食品技術中心（TKH）、食品科技孵化器和施特勞斯集團的投資部門合作成立。最後，食品利用Evogene的人工智能技術，通過改造植物作爲 “生物反應器” 來生產動物基蛋白。它的第一個目標蛋白是酪蛋白。
More on
更多內容
Forward Looking Statements
前瞻性陳述
This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", "could", "expects", "hopes" "intends", "anticipates", "plans", "believes", "scheduled", "estimates", "demonstrates" or words of similar meaning. For example, Evogene and its subsidiaries are using forward-looking statement in this press release when it discusses Finally Foods ability to produce proteins and express them in plants, in a cost effective and sustainable manner, Finally Foods seizure of a share in the molecular farming sector. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, the current war between Israel and Hamas and any worsening of the situation in Israel such as further mobilizations or escalation in the northern border of Israel and those risk factors contained in Evogene's reports filed with the applicable securities authority. In addition, Evogene and its subsidiaries rely, and expect to continue to rely, on third parties to conduct certain activities, such as their field-trials and pre-clinical studies, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, Evogene and its subsidiaries may experience significant delays in the conduct of their activities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
本新聞稿包含與未來事件有關的 “前瞻性陳述”。這些陳述可以通過諸如 “可能”、“可能”、“期望”、“打算”、“預期”、“計劃”、“相信”、“預定”、“預定”、“估計”、“證實” 等詞語或類似含義的詞語來識別。例如，Evogene及其子公司在本新聞稿中使用了前瞻性陳述，討論Finally Foods以具有成本效益和可持續的方式生產蛋白質並在植物中表達蛋白質的能力，Finally Foods收購分子農業領域的股份。 此類陳述基於當前的預期、估計、預測和假設，描述了對未來事件的看法，涉及某些風險和不確定性，這些風險和不確定性難以預測，也不能保證未來的表現。因此，Evogene及其子公司未來的實際業績、業績或成就可能與此類前瞻性陳述所表達或暗示的內容存在重大差異，其中許多因素是Evogene及其子公司無法控制的，包括但不限於當前的以色列和哈馬斯之間的戰爭以及以色列局勢的任何惡化，例如以色列北部邊境的進一步動員或升級 和 Evogene向相關證券管理局提交的報告中包含的那些風險因素。此外，Evogene及其子公司依賴並預計將繼續依賴第三方來開展某些活動，例如實地試驗和臨床前研究，如果這些第三方未能成功履行合同職責、遵守監管要求或在預期的最後期限之前完成工作，Evogene及其子公司在開展活動時可能會遇到重大延誤。Evogene及其子公司不承擔任何義務或承諾更新這些前瞻性陳述以反映未來事件或發展或預期、估計、預測和假設的變化。
Investor Relations Contact
投資者關係聯繫人
Rachel Pomerantz Gerber I Head of Investor Relations at Evogene
Rachel Pomerantz Gerber 我是 Evogene 投資者關係主管
[email protected] I Tel: +972-8-9311901
[email protected] 我電話：+972-8-9311901
[1]
[1]
Logo -
徽標-
SOURCE Evogene
來源 Evogene
譯文內容由第三人軟體翻譯。